SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.
Watch this video of Dr. Achintya Das, Head of Computational & Data Sciences, speaking about Syngene’s proprietary modeling and AI solutions which help scientists make informed decisions across phases of drug discovery. He also talks about Syngene’s virtual liver platform, HepTox, used for mechanistic assessment of exposure-dependent hepatotoxicity.
Watch this video where our VP and Head of Discovery Biology, Dr. Jayashree Aiyar, speaks about her journey at Syngene and how the biotech industry has evolved over the last few years. An industry veteran with 25 years of experience, she highlights key research areas that global pharma and biotechs are currently focusing on, including exciting projects at Syngene spanning PROTACs, Cell and Gene therapy, Omics, and more.
Watch this video where our Head of Human Pharmacology Unit (HPU), Dr. Anil talks about his journey & how Syngene can support clinical R&D programs & enables clients to fulfill their regulatory requirements.
Watch this video where our Research Director, Dr. Santosh Kulkarni explains how Syngene delivers Chemistry services for drug discovery programs using cutting-edge science.
Watch this video on ‘Life at Syngene’ where we speak to Chetan Tamhankar, Head, Clinical Development services on Syngene capabilities in this space, the value we bring to our clients, future plans, and more.
Learn from our Head of bioanalytical Lab, Aparna Kasinath, how the field of biotherapeutics has evolved over the past decade, interesting projects at Syngene, and what makes Syngene so unique as a CRO/CDMO
Watch this video on what our Research Director, Jayadeva Sajankila, has to say on what makes Syngene unique, new expectations driving drug development today, and more.
Watch this video on what our Head of DMPK services Dr. Vishwottam Kandikere, has to say on what sets Syngene apart, emerging trends in DMPK, our current projects related to new modalities, and more.
In continuation of our earlier video on ‘Life at Syngene,’ learn from our Research Director, Jayadeva Sajankila, Syngene’s unique capabilities in Solid-state chemistry and how Safety is at the heart of everything we do – personally and professionally.
Watch this video to get insights on how Syngene’s Stability Center, one of the largest ICH Stability Centers in Asia, is delivering successfully even in the midst of a pandemic.
© 2024. Syngene International Limited